litlas
ログインアカウント作成

David R. Lynch

1984–2025 年に発表

121
論文数
22,553
被引用数
73
h 指数
116
i10 指数

被引用数

David R. Lynch の年別被引用数1985 年: 被引用 1 件1986 年: 被引用 2 件1987 年: 被引用 2 件1988 年: 被引用 4 件1989 年: 被引用 5 件1990 年: 被引用 3 件1991 年: 被引用 6 件1992 年: 被引用 3 件1993 年: 被引用 5 件1994 年: 被引用 3 件1995 年: 被引用 8 件1996 年: 被引用 20 件1997 年: 被引用 25 件1998 年: 被引用 29 件1999 年: 被引用 28 件2000 年: 被引用 29 件2001 年: 被引用 38 件2002 年: 被引用 35 件2003 年: 被引用 36 件2004 年: 被引用 42 件2005 年: 被引用 71 件2006 年: 被引用 84 件2007 年: 被引用 122 件2008 年: 被引用 141 件2009 年: 被引用 134 件2010 年: 被引用 206 件2011 年: 被引用 239 件2012 年: 被引用 226 件2013 年: 被引用 200 件2014 年: 被引用 249 件2015 年: 被引用 207 件2016 年: 被引用 184 件2017 年: 被引用 210 件2018 年: 被引用 155 件2019 年: 被引用 652 件2020 年: 被引用 612 件2021 年: 被引用 586 件2022 年: 被引用 481 件2023 年: 被引用 358 件2024 年: 被引用 646 件2025 年: 被引用 305 件2026 年: 被引用 6 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,727 件、この内訳の 28%中国: 引用元論文 471 件、この内訳の 7.7%イギリス: 引用元論文 461 件、この内訳の 7.5%ドイツ: 引用元論文 459 件、この内訳の 7.5%イタリア: 引用元論文 365 件、この内訳の 5.9%スペイン: 引用元論文 301 件、この内訳の 4.9%フランス: 引用元論文 286 件、この内訳の 4.6%カナダ: 引用元論文 241 件、この内訳の 3.9%オーストラリア: 引用元論文 217 件、この内訳の 3.5%日本: 引用元論文 151 件、この内訳の 2.5%オランダ: 引用元論文 133 件、この内訳の 2.2%スイス: 引用元論文 119 件、この内訳の 1.9%
0%28%その他 19.9%

機関

分野

  • Medicine52.1%
  • Neuroscience25.7%
  • Biochemistry, Genetics and Molecular Biology19%
  • Immunology and Microbiology1.5%
  • Psychology0.4%
  • Nursing0.3%
  • その他1%

トピック

  • Autoimmune Neurological Disorders and Treatments9.2%
  • Genetic Neurodegenerative Diseases5.3%
  • Neuroscience and Neuropharmacology Research5.2%
  • Mitochondrial Function and Pathology4.4%
  • Parkinson's Disease Mechanisms and Treatments3.8%
  • Peripheral Neuropathies and Disorders3.2%
  • その他68.9%

共著者

全論文

検索で開く
  1. Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma

    著者: Josep Dalmau, Erdem Tüzün, Haiyan Wu, Jaime Masjuan, Jeffrey Rossi, Alfredo Voloschin, Joachim M. Baehring, Haruo Shimazaki, Reiji Koide, Dale King, Warren Mason, Lauren Sansing, Marc A. Dichter, Myrna R. Rosenfeld, David R. Lynch - Annals of Neurology 2007 被引用: 2,466

  2. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

    著者: Josep Dalmau, Amy J. Gleichman, Ethan G. Hughes, Jeffrey Rossi, Xiaoyu Peng, Meizan Lai, Scott Dessain, Myrna R. Rosenfeld, Rita J. Balice‐Gordon, David R. Lynch - The Lancet Neurology 2008 被引用: 3,459

  3. Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)

    著者: David R. Lynch, Melanie Chin, Martin B. Delatycki, S. H. Subramony, Manuela Corti, J. Chad Hoyle, Sylvia Boesch, Wolfgang Nachbauer, Caterina Mariotti, Katherine D. Mathews, Paola Giunti, George Wilmot, Theresa A. Zesiewicz, Susan Perlman, Angie Goldsberry, Megan A. O’Grady, Colin J. Meyer - Annals of Neurology 2020 被引用: 296

  4. Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis

    著者: Ethan G. Hughes, Xiaoyu Peng, Amy J. Gleichman, Meizan Lai, Lei Zhou, Ryan Tsou, Thomas D. Parsons, David R. Lynch, Josep Dalmau, Rita J. Balice‐Gordon - Journal of Neuroscience 2010 被引用: 1,127

  5. Mitochondrial dysfunction in the development and progression of neurodegenerative diseases

    著者: Joseph Johnson, Elizabeth Mercado‐Ayón, Yesica Mercado-Ayon, Yi Dong, Sarah Halawani, Lucie Ngaba, David R. Lynch - Archives of Biochemistry and Biophysics 2020 被引用: 252

  6. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study

    著者: Núria Gresa‐Arribas, Maarten J. Titulaer, Abiguei Torrents, Esther Aguilar, Lindsey McCracken, Frank Leypoldt, Amy J. Gleichman, Rita J. Balice‐Gordon, Myrna R. Rosenfeld, David R. Lynch, Francesc Graus, Josep Dalmau - The Lancet Neurology 2013 被引用: 1,286

  7. Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed‐Start Analysis of the MOXIe Extension

    著者: David R. Lynch, Melanie Chin, Sylvia Boesch, Martin B. Delatycki, Paola Giunti, Angie Goldsberry, J. Chad Hoyle, Caterina Mariotti, Katherine D. Mathews, Wolfgang Nachbauer, Megan O’Grady, Susan Perlman, S. H. Subramony, George Wilmot, Theresa A. Zesiewicz, Colin J. Meyer - Movement Disorders 2022 被引用: 115

  8. Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia

    著者: David R. Lynch, Jennifer Farmer, Lauren Hauser, Ian A. Blair, Qing Qing Wang, Clementina Mesaros, Nathaniel W. Snyder, Sylvia Boesch, Melanie Chin, Martin B. Delatycki, Paola Giunti, Angela Goldsberry, Chad Hoyle, Michael G. McBride, Wolfgang Nachbauer, Megan O’Grady, Susan Perlman, S. H. Subramony, George Wilmot, Theresa A. Zesiewicz, Colin J. Meyer - Annals of Clinical and Translational Neurology 2018 被引用: 166

  9. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location

    著者: Meizan Lai, Ethan G. Hughes, Xiaoyu Peng, Lei Zhou, Amy J. Gleichman, Huidy Shu, Sabrina Matà, Daniel Kremens, Roberta Vitaliani, Michael D. Geschwind, Luís Bataller, Robert G. Kalb, Rebecca Davis, Francesc Graus, David R. Lynch, Rita J. Balice‐Gordon, Josep Dalmau - Annals of Neurology 2009 被引用: 803

  10. Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale

    著者: S. H. Subramony, William May, David R. Lynch, C. M. Gomez, Kenneth H. Fischbeck, Maurice B. Hallett, J. Paul Taylor, Roneé E. Wilson, Tetsuo Ashizawa - Neurology 2005 被引用: 388

  11. Mortality in Friedreich Ataxia

    著者: Amy Y. Tsou, Erin K. Paulsen, Sarah J. Lagedrost, Susan Perlman, Katherine D. Mathews, George Wilmot, Bernard Ravina, Arnulf H. Koeppen, David R. Lynch - Journal of the Neurological Sciences 2011 被引用: 307

  12. Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data

    著者: David R. Lynch, Angie Goldsberry, Christian Rummey, Jennifer Farmer, Sylvia Boesch, Martin B. Delatycki, Paola Giunti, J. Chad Hoyle, Caterina Mariotti, Katherine D. Mathews, Wolfgang Nachbauer, Susan Perlman, S. H. Subramony, George Wilmot, Theresa A. Zesiewicz, Lisa A. Weissfeld, Colin J. Meyer - Annals of Clinical and Translational Neurology 2023 被引用: 47

  13. Friedreich Ataxia: Clinical Features and New Developments

    著者: Medina Keita, Kellie McIntyre, Layne N. Rodden, Kim Schadt, David R. Lynch - Neurodegenerative Disease Management 2022 被引用: 73

  14. Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents

    著者: Nicole R. Florance, Rebecca Davis, Christopher Wai Kei Lam, Christina L. Szperka, Lei Zhou, Saba Ahmad, Cynthia Campen, Heather E. Moss, Nadja G. Peter, Amy J. Gleichman, Carol Glaser, David R. Lynch, Myrna R. Rosenfeld, Josep Dalmau - Annals of Neurology 2009 被引用: 1,097

  15. Functional Consequences of α-Synuclein Tyrosine Nitration

    著者: Roberto Hodara, Erin H. Norris, Benoit I. Giasson, Amanda J. Mishizen-Eberz, David R. Lynch, Virginia M.‐Y. Lee, Harry Ischiropoulos - Journal of Biological Chemistry 2004 被引用: 283

  16. Natural History of Friedreich Ataxia

    著者: Christian Rummey, Louise A. Corben, Martin B. Delatycki, George Wilmot, S. H. Subramony, Manuela Corti, Khalaf Bushara, Antoine Duquette, Christopher M. Gómez, J. Chad Hoyle, Richard Roxburgh, Lauren Seeberger, Grace Yoon, Katherine D. Mathews, Theresa A. Zesiewicz, Susan Perlman, David R. Lynch - Neurology 2022 被引用: 63

  17. Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia

    著者: Victoria Profeta, Kellie McIntyre, McKenzie Wells, Courtney Park, David R. Lynch - Expert Opinion on Investigational Drugs 2023 被引用: 38

  18. Anti-NMDA Receptor Encephalitis Antibody Binding Is Dependent on Amino Acid Identity of a Small Region within the GluN1 Amino Terminal Domain

    著者: Amy J. Gleichman, Lynn A. Spruce, Josep Dalmau, Steven H. Seeholzer, David R. Lynch - Journal of Neuroscience 2012 被引用: 285

  19. Double-blind, Randomized and Controlled Trial of EPI-743 in Friedreich’s Ataxia

    著者: Theresa A. Zesiewicz, Jason L. Salemi, Susan Perlman, Kelly L. Sullivan, Jessica Shaw, Yangxin Huang, Charles J. Isaacs, Clifton L. Gooch, David R. Lynch, Matthew B. Klein - Neurodegenerative Disease Management 2018 被引用: 84

  20. Distinct cleavage patterns of normal and pathologic forms of α‐synuclein by calpain I in vitro

    著者: Amanda J. Mishizen-Eberz, Rodney P. Guttmann, Benoit I. Giasson, George A. Day, Roberto Hodara, Harry Ischiropoulos, Virginia M.‐Y. Lee, John Q. Trojanowski, David R. Lynch - Journal of Neurochemistry 2003 被引用: 160

  21. Compound heterozygous FXN mutations and clinical outcome in friedreich ataxia

    著者: Charles A. Galea, Aamira Huq, Paul J. Lockhart, Geneieve Tai, Louise A. Corben, Eppie M. Yiu, Lyle C. Gurrin, David R. Lynch, Sarah Gelbard, Alexandra Dürr, Françoise Pousset, Michael Parkinson, Robyn Labrum, Paola Giunti, Susan Perlman, Martin B. Delatycki, Marguerite V. Evans‐Galea - Annals of Neurology 2015 被引用: 152

  22. Predictors of loss of ambulation in Friedreich's ataxia

    著者: Christian Rummey, Jennifer Farmer, David R. Lynch - EClinicalMedicine 2020 被引用: 66

  23. Central Nervous System Therapeutic Targets in Friedreich Ataxia

    著者: Ian H. Harding, David R. Lynch, Arnulf H. Koeppen, Massimo Pandolfo - Human Gene Therapy 2020 被引用: 49

  24. Measuring Friedreich ataxia

    著者: David R. Lynch, Jennifer Farmer, Amy Y. Tsou, Susan Perlman, S. H. Subramony, C. M. Gomez, Tetsuo Ashizawa, George Wilmot, Robert B. Wilson, Laura J. Balcer - Neurology 2006 被引用: 218